During the last session, Allarity Therapeutics Inc (NASDAQ:ALLR)’s traded shares were 9.44 million, with the beta value of the company hitting 0.24. At the end of the trading day, the stock’s price was $1.32, reflecting an intraday gain of 30.69% or $0.31. The 52-week high for the ALLR share is $288.00, that puts it down -21718.18 from that peak though still a striking 31.82% gain since the share price plummeted to a 52-week low of $0.90. The company’s market capitalization is $5.86M, and the average intraday trading volume over the past 10 days was 3.6 million shares, and the average trade volume was 1.03 million shares over the past three months.
Allarity Therapeutics Inc (ALLR) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. ALLR has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
Allarity Therapeutics Inc (ALLR) registered a 30.69% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 30.69% in intraday trading to $1.32, hitting a weekly high. The stock’s 5-day price performance is 33.31%, and it has moved by 28.16% in 30 days. Based on these gigs, the overall price performance for the year is -99.50%. The short interest in Allarity Therapeutics Inc (NASDAQ:ALLR) is 0.18 million shares and it means that shorts have 0.3 day(s) to cover.
Allarity Therapeutics Inc (ALLR) estimates and forecasts
Statistics show that Allarity Therapeutics Inc has outperformed its competitors in share price, compared to the industry in which it operates. Allarity Therapeutics Inc (ALLR) shares have gone down -73.57% during the last six months, with a year-to-date growth rate more than the industry average at 98.73% against 16.50.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 57.56%.
ALLR Dividends
Allarity Therapeutics Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Allarity Therapeutics Inc (NASDAQ:ALLR)’s Major holders
Allarity Therapeutics Inc insiders own 12.32% of total outstanding shares while institutional holders control 2.21%, with the float percentage being 2.52%.
